Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
Infect Dis (Lond). 2023 Oct;55(10):716-724. doi: 10.1080/23744235.2023.2234033. Epub 2023 Jul 21.
The World Health Organization has adopted a resolution on sepsis and urged member states to develop national processes to improve sepsis care. In Sweden, sepsis was selected as one of the ten first diagnoses to be addressed, when the Swedish government in 2019 allocated funds for patient-centred clinical pathways in healthcare. A national multidisciplinary working group, including a patient representative, was appointed to develop the patient-centred clinical pathway for sepsis.
The working group mapped challenges and needs surrounding sepsis care and included a survey sent to all emergency departments (ED) in Sweden, and then designed a patient-centred clinical pathway for sepsis.
The working group decided to focus on the following four areas: (1) sepsis alert for early detection and management optimisation for the most severely ill sepsis patients in the ED; (2) accurate sepsis diagnosis coding; (3) structured information to patients at discharge after sepsis care and (4) structured telephone follow-up after sepsis care. A health-economic analysis indicated that the implementation of the clinical pathway for sepsis will most likely not drive costs. An important aspect of the clinical pathway is implementing continuous monitoring of performance and process indicators. A national working group is currently building up such a system for monitoring, focusing on extraction of this information from the electronic health records systems.
A national patient-centred clinical pathway for sepsis has been developed and is currently being implemented in Swedish healthcare. We believe that the clinical pathway and the accompanying monitoring will provide a more efficient and equal sepsis care and improved possibilities to monitor and further develop sepsis care in Sweden.
世界卫生组织通过了一项关于脓毒症的决议,并敦促成员国制定国家流程,以改善脓毒症的护理。在瑞典,当 2019 年瑞典政府为医疗保健中的以患者为中心的临床路径分配资金时,脓毒症被选为需要解决的十大首要诊断之一。一个包括患者代表在内的国家多学科工作组被任命来制定脓毒症的以患者为中心的临床路径。
工作组绘制了脓毒症护理相关的挑战和需求图,并向瑞典所有的急症室发送了一份调查,然后为脓毒症设计了以患者为中心的临床路径。
工作组决定专注于以下四个方面:(1)脓毒症预警,以便在急症室对病情最严重的脓毒症患者进行早期发现和管理优化;(2)准确的脓毒症诊断编码;(3)在脓毒症护理后向患者提供结构化信息;(4)在脓毒症护理后进行结构化电话随访。一项健康经济学分析表明,实施脓毒症临床路径不太可能增加成本。该临床路径的一个重要方面是实施对绩效和流程指标的持续监测。一个国家工作组目前正在建立这样一个监测系统,重点是从电子健康记录系统中提取这些信息。
已制定了国家脓毒症以患者为中心的临床路径,并正在瑞典的医疗保健中实施。我们相信,该临床路径和伴随的监测将提供更高效、更公平的脓毒症护理,并为瑞典脓毒症护理的监测和进一步发展提供了更好的可能性。